Class: Cancer

Alimta 

(pemetrexed)

Class: Cancer
Back to: Full Site NavigationSkip to: side effects sectionSkip to: What to expect sectionSkip to: Risks and warnings sectionSkip to: Common concerns from users and pharmacists
Skip side effects section. Skip to What to Expect and Pharmacists Tips section.

Side effect rates for Alimta (pemetrexed)

830 From clinical trials of Alimta / Non-small cell lung cancer Grade 3-4
  • Low white blood cells
  • Fatigue
  • Nausea
  • Low red blood cells
  • Vomiting
  • Low white blood cells
  • Thrombocytopenia
  • Loss of appetite

Common concerns from people taking Alimta (pemetrexed)

Final section. Do you want to return to drug navigation?
Pregnancy